Log in to save to my catalogue

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastom...

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastom...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0478454b0efe490085728f5f7fd46931

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

About this item

Full title

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

Publisher

England: BioMed Central Ltd

Journal title

Molecular cancer, 2020-02, Vol.19 (1), p.28-19, Article 28

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Accumulating evidence shows that long noncoding RNAs (lncRNAs) are important regulator molecules involved in diverse biological processes. Acquired drug resistance is a major challenge in the clinical treatment of glioblastoma (GBM), and lncRNAs have been shown to play a role in chemotherapy resistance. However, the underlying mechanisms by which l...

Alternative Titles

Full title

DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0478454b0efe490085728f5f7fd46931

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0478454b0efe490085728f5f7fd46931

Other Identifiers

ISSN

1476-4598

E-ISSN

1476-4598

DOI

10.1186/s12943-020-1137-5

How to access this item